PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Correlation Between Disease Stage and the Presence of Viable Circulating Tumor Cells in Endometrial Cancer.

Abstract The presence of circulating tumor cells (CTCs) in the peripheral blood of patients with solid tumors is associated with a poor prognosis. However, there are limited data concerning the detection of CTCs in endometrial cancer (EC). The aim of this study was to evaluate the presence of CTCs in the peripheral blood of patients with EC.
PMID
Related Publications

Circulating tumor cells in pancreatic cancer patients: enrichment and cultivation.

Circulating tumor cells in localized prostate cancer: isolation, cultivation in vitro and relationship to T-stage and Gleason score.

Detection of circulating tumor cells in high-risk endometrial cancer.

Detection of circulating tumour cells may add value in endometrial cancer management.

In vitro culturing of viable circulating tumor cells of urinary bladder cancer.

Authors

Mayor MeshTerms
Keywords

CTCs

circulating tumor cells

culturing

endometrial cancer

Journal Title anticancer research
Publication Year Start




PMID- 29715128
OWN - NLM
STAT- MEDLINE
DCOM- 20180508
LR  - 20180508
IS  - 1791-7530 (Electronic)
IS  - 0250-7005 (Linking)
VI  - 38
IP  - 5
DP  - 2018 May
TI  - Correlation Between Disease Stage and the Presence of Viable Circulating Tumor
      Cells in Endometrial Cancer.
PG  - 2983-2987
AB  - BACKGROUND/AIM: The presence of circulating tumor cells (CTCs) in the peripheral 
      blood of patients with solid tumors is associated with a poor prognosis. However,
      there are limited data concerning the detection of CTCs in endometrial cancer
      (EC). The aim of this study was to evaluate the presence of CTCs in the
      peripheral blood of patients with EC. MATERIALS AND METHODS: Peripheral blood
      samples from 92 patients who underwent a surgical procedure were evaluated using 
      MetaCell(R) separation technology for CTCs. RESULTS: CTCs were detected in 69
      (75%) patients with EC. CONCLUSION: CTCs were detected in a higher percentage of 
      patients than in other studies. The results showed that the technology applied in
      this study can efficiently capture viable tumor cells in the blood that can be
      cultured while maintaining their original phenotype. This paper discusses the
      first successful culturing of human circulating endometrial cancer cells for
      further downstream functional and molecular characterization.
CI  - Copyright(c) 2018, International Institute of Anticancer Research (Dr. George J. 
      Delinasios), All rights reserved.
FAU - Kiss, Imrich
AU  - Kiss I
AD  - Department of Laboratory Genetics, University Hospital Kralovske Vinohrady,
      Prague, Czech Republic.
AD  - Department of Gynecology, Military University Hospital and 3 Faculty of Medicine 
      Charles University, Prague, Czech Republic.
FAU - Kolostova, Katarina
AU  - Kolostova K
AD  - Department of Laboratory Genetics, University Hospital Kralovske Vinohrady,
      Prague, Czech Republic.
FAU - Matkowski, Rafal
AU  - Matkowski R
AD  - Division of Surgical Oncology, Gynaecological Oncology and Department of
      Oncology, Lower Silesian Cancer Center and Wroclaw Medical University, Wroclaw,
      Poland.
FAU - Jedryka, Marcin
AU  - Jedryka M
AD  - Division of Surgical Oncology, Gynaecological Oncology and Department of
      Oncology, Lower Silesian Cancer Center and Wroclaw Medical University, Wroclaw,
      Poland.
FAU - Czekanski, Andrzej
AU  - Czekanski A
AD  - Division of Surgical Oncology, Gynaecological Oncology and Department of
      Oncology, Lower Silesian Cancer Center and Wroclaw Medical University, Wroclaw,
      Poland.
FAU - Pavlasek, Jiri
AU  - Pavlasek J
AD  - Department of Obstetrics and Gynecology, Hospital Liberec, Liberec, Czech
      Republic.
FAU - Bobek, Vladimir
AU  - Bobek V
AD  - Department of Laboratory Genetics, University Hospital Kralovske Vinohrady,
      Prague, Czech Republic [email protected]
AD  - 3rd Department of Surgery University Hospital Motol and 1st Faculty of Medicine
      Charles University, Prague, Czech Republic.
AD  - Department of Thoracic Surgery, Masaryk's Hospital, Usti nad Labem, Czech
      Republic.
AD  - Department of Histology and Embryology, Wroclaw Medical University, Wroclaw,
      Poland.
AD  - Department of Thoracic Surgery, Lower Silesian Cancer Center, Wroclaw, Poland.
LA  - eng
PT  - Journal Article
PL  - Greece
TA  - Anticancer Res
JT  - Anticancer research
JID - 8102988
SB  - IM
MH  - Endometrial Neoplasms/*blood/*pathology
MH  - Female
MH  - Humans
MH  - Neoplasm Staging
MH  - Neoplastic Cells, Circulating/*pathology
OTO - NOTNLM
OT  - *CTCs
OT  - *circulating tumor cells
OT  - *culturing
OT  - *endometrial cancer
EDAT- 2018/05/02 06:00
MHDA- 2018/05/09 06:00
CRDT- 2018/05/02 06:00
PHST- 2018/03/15 00:00 [received]
PHST- 2018/04/01 00:00 [revised]
PHST- 2018/04/02 00:00 [accepted]
PHST- 2018/05/02 06:00 [entrez]
PHST- 2018/05/02 06:00 [pubmed]
PHST- 2018/05/09 06:00 [medline]
AID - 38/5/2983 [pii]
AID - 10.21873/anticanres.12550 [doi]
PST - ppublish
SO  - Anticancer Res. 2018 May;38(5):2983-2987. doi: 10.21873/anticanres.12550.